Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 111, Issue 9, 2004, Pages 996-1000

  Hamoda, H ^a   Ashok, P W ^a   Flett, G M M ^a   Templeton, A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DICLOFENAC; MIFEPRISTONE; MISOPROSTOL; OPIATE;

ABDOMINAL PAIN; ADULT; ANALGESIA; ANAMNESIS; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADULT; ANALGESIA; ANALGESIA, OBSTETRICAL; ANALGESICS; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PAIN; PREGNANCY; PREGNANCY TRIMESTER, SECOND; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 4544365020     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00235.x     Document Type: Article

References (20)

1. Ashok PW, Kidd A, Flett GM, Fitzmaurice A, Graham W, Templeton A. A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation. Hum Reprod 2002;17(1):92-98.
2. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Br J Obstet Gynaecol 2002;109(11):1281-1289.
3. Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000;62(6):297-303.
4. Henshaw RC, Naji SA, Russell IT, Templeton AA. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. Hum Reprod 1994;9(11):2167-2172.
5. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338(18):1241-1247.
6. Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 2004;69(1):51-58.
7. Ashok PW, Templeton A. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynaecol 1999;106(7):706-710.
8. OFNS. Abortion Statistics: Series AB No. 28. Legal Abortion in England and Wales 2001. London: Office for National Statistics, 2002.
9. Information and Statistics Division. Abortion Statistics in Scotland 2002 - ISD Scotland Health Briefing. Edinburgh: ISD, 2003.
10. UK Multicentre Study Group. Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. An open multicenter study. Contraception 1997;56(6):361-366.
11. UK Multicentre Study - Final Results. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study - final results. Contraception 1997;55(1):1-5.
12. UK Multicentre Trial. The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. UK Multicentre Trial. Br J Obstet Gynaecol 1990;97(6):480-486.
13. Westhoff C, Dasmahapatra R, Winikoff B, Clarke S. Predictors of analgesia use during supervised medical abortion. The Mifepristone Clinical Trials Group. Contraception 2000;61(3):225-229.
14. Westhoff C, Dasmahapatra R, Schaff E. Analgesia during at-home use of misoprostol as part of a medical abortion regimen. Contraception 2000;62(6):311-314.
15. Grimes DA. Medical abortion in early pregnancy: a review of the evidence. Obstet Gynecol 1997;89(5 Pt 1):790-796.
16. Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998;13(10):2962-2965.
17. Ashok PW, Flett GM, Templeton A. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol. Lancet 1998;352(9127):542-543.
18. Hamoda H, Ashok PW, Flett GMM, Templeton A. Medical abortion at 64 to 91 days gestation: a review of 483 consecutive cases. Am J Obstet Gynecol 2003;188(5):1315-1319.
19. Robinson HP. Sonar measurement of fetal crown-rump length as means of assessing maturity in first trimester of pregnancy. BMJ 1973;4(5883):28-31.
20. El Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;332(15):983-987.